Summary of Significant Accounting Policies (Details) |
12 Months Ended | ||
|---|---|---|---|
|
Dec. 31, 2024
USD ($)
shares
|
Dec. 31, 2023
USD ($)
|
Mar. 31, 2025
USD ($)
shares
|
|
| Summary of Significant Accounting Policies [Line Items] | |||
| Exchange rate | 3.647 | 3.627 | 3.718 |
| FDIC insurance limit | $ 0 | $ 145,168 | $ 52,019 |
| Cash uninsured amount | $ 544,175 | 2,935,078 | $ 47,832 |
| Tax benefit percentage | 50.00% | ||
| General and administrative expenses | $ 59,027 | ||
| Common Stock [Member] | |||
| Summary of Significant Accounting Policies [Line Items] | |||
| Shares converted (in Shares) | shares | 100 | 100 | |
| X | ||||||||||
- Definition The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation. No definition available.
|
| X | ||||||||||
- Definition The amount of cash as of the balance sheet date that is not insured by the Federal Deposit Insurance Corporation. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of shares issued for each share of convertible preferred stock that is converted. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to income exempt from income tax because of a tax holiday. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Foreign exchange rate used to translate amounts denominated in functional currency to reporting currency. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of other research and development expense. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Details
|